Offer - Urjas Oil for just ₹ 1 X
Cyclomune 0.05 % Eye Drop is a commercial drug that is prescribed in the form of Drops. It is typically used for the treatment of Psoriasis, Liver transplant. Other than this, Cyclomune 0.05 % Eye Drop has some other therapeutic uses, which have been discussed ahead.
The right dosage of Cyclomune 0.05 % Eye Drop depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Cyclomune 0.05 % Eye Drop also has some side effects, the most common being Increased hair growth, Loss of appetite. Some other side effects of Cyclomune 0.05 % Eye Drop have been listed ahead. Usually, these side effects of Cyclomune 0.05 % Eye Drop go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Cyclomune 0.05 % Eye Drop is Unknown for pregnant women and Severe for women who are breastfeeding. In addition, Cyclomune 0.05 % Eye Drop's effects on the liver, heart and kidney are discussed below in the Cyclomune 0.05 % Eye Drop related warnings section.
Cyclomune 0.05 % Eye Drop is contraindicated in people with pre-existing medical conditions like Liver Disease as it can result in adverse effects. The section on Cyclomune 0.05 % Eye Drop contraindications lists all such conditions.
Additionally, Cyclomune 0.05 % Eye Drop may also adversely react with other medicines. A complete list of these interactions is given below.
You should also be aware that Cyclomune 0.05 % Eye Drop is safe while driving, and is addiction.
Cyclomune 0.05 % Eye Drop is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Is the use of Cyclomune 0.05 % Eye Drop safe for pregnant women?
No research has not been done till date on the safety of Cyclomune for pregnant women. So its effects on pregnant women are unknown.
Is the use of Cyclomune 0.05 % Eye Drop safe during breastfeeding?
Cyclomune should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Cyclomune 0.05 % Eye Drop on the Kidneys?
Cyclomune may have mild side effects on the kidneys.
What is the effect of Cyclomune 0.05 % Eye Drop on the Liver?
Cyclomune is rarely harmful for the liver.
What is the effect of Cyclomune 0.05 % Eye Drop on the Heart?
Very few cases of side effects of Cyclomune on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Cyclomune 0.05 % Eye Drop unless your doctor advises you to do so -
Is this Cyclomune 0.05 % Eye Drop habit forming or addictive?
Cyclomune 0.05 % Eye Drop is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Cyclomune 0.05 % Eye Drop does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Yes, but take Cyclomune 0.05 % Eye Drop only as per medical advice.
Is it able to treat mental disorders?
No, Cyclomune 0.05 % Eye Drop cannot treat any kind of mental disorder.
Interaction between Food and Cyclomune 0.05 % Eye Drop
Eating certain foods may increase the time it takes Cyclomune 0.05 % Eye Drop to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Cyclomune 0.05 % Eye Drop
Taking alcohol with Cyclomune 0.05 % Eye Drop can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sandimmune® (cyclosporine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 876-881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 377-380